Olaparib With Ceralasertib in Recurrent Osteosarcoma
Clinical trial NCT04417062 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04417062
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2025-06-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.